Substance / Medication

Verapamil hydrochloride

Overview

Clinical overview including description, indications, and evidence base is pending physician authorship or FDA SPL integration. Graph-derived relationship data is available below.

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Administration & Protocol

Dosing, route, and treatment protocol

Administration details including route, dosing schedules, preparation instructions, and contraindications are pending physician authorship.

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

Research Evidence

Published studies and systematic reviews

Sort:
Sustained release of verapamil hydrochloride from sodium alginate microcapsules.
Farhana S Ayesha, Shantakumar S M, Shyale Somashekar et al. · Curr Drug Deliv · 2010
PMID: 20158489Observational
Design and evaluation of 1- and 3-layer matrices of verapamil hydrochloride for sustaining its release.
Siahi Mohammad Reza, Barzegar-Jalali Mohammad, Monajjemzadeh Farnaz et al. · AAPS PharmSciTech · 2005
PMID: 16408864ObservationalFull text (PMC)
Novel chewable sustained-release tablet containing verapamil hydrochloride.
El-Gazayerly Omaima N, Rakkanka Vipaporn, Ayres James W · Pharm Dev Technol · 2004
PMID: 15202577Observational
Tarka® (trandolapril/verapamil hydrochloride extended-release) overdose.
Cohen Victor, Jellinek Samantha P, Fancher Lydia et al. · J Emerg Med · 2011
PMID: 19249183Case Report
Repurposing verapamil hydrochloride with niosomal gel technology: Enhanced efficacy and skin penetration in hypertrophic scars.
Namdeo Shraddha, Vishwakarma Monika, Haider Tanweer et al. · Burns · 2025
PMID: 40424672Preclinical

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Risk profile, common and serious adverse effects, contraindications, and drug interactions are pending physician authorship.

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Health Goals

Goals connected through associated conditions

Quick Facts

Type
Substance / Medication
Fully Specified Name
Verapamil hydrochloride (substance)
SNOMED CT
14340003
UMLS CUI
C0700468

Clinical Data

This intervention maps to 15 entities in the Ltrl knowledge graph.

6
Conditions
4
Biomarkers
3
Specialists
0
Symptoms

Data is sourced from SNOMED CT, UMLS, and the Ltrl clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.